MedPath

Laparoscopic "DA VINCI" Robot Assisted Abdominal Wall Hernia Repair

Phase 4
Completed
Conditions
Abdominal Wall Hernia
Interventions
Device: Laparoscopic DA VINCI Robot Assisted coelioscopy
Procedure: conventional coelioscopy
Registration Number
NCT00908193
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

The aim of this study is to prove the superiority of the robotic assistance in laparoscopic repair of abdominal wall hernias .

In this monocentric randomized controlled trial, the use of the DA VINCI robot might reduce the post-operative pain of the patient resulting in a 40% reduction of morphine consumption.

Detailed Description

Laparoscopic Robot Assisted abdominal wall hernia repair : a prospective randomized trial:

The main judgement criterion is post operative pain reflected by morphine consumption during the first 48 hours. Secondary criteria are morbidity, quality of life, duration of surgery, conversion rate, complications, the the length of stay and hospital costs.

In this single centre study, inclusion criteria are age above 18, no previous repair of the hernia with a mesh and a diameter of the parietal defect of less than 10 cm. Contraindications are chronic use of pain drugs of level II or above and renal insufficiency (clearance \<30ml/min).

The robotic repair was described in a previous paper of our group and will be compared to our classical laparoscopic repair technique, and in both cases with the use of the same prosthetic mesh.

A total of 70 patients to be included in an 18 months period was calculated to prove a 40% reduction in morphine consumption during the postoperative 48h (α=5% and β=10%).

The total duration of the study is 30 months (12 months of follow-up for each patient).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • over 18 years
  • with indication of hernia repair
  • a collar with a diameter of less than 10cm
  • no antecedent of hernia treatment with poses plate
  • agreeing coelioscopy
  • agreeing to participate the clinical study, having sign an informed consent
  • agreeing a regular monitor
Read More
Exclusion Criteria
  • taking analgesic tier 2 or 3
  • against indication to anesthetics or coelioscopy
  • creatinine clearance less than 30 ml/min
  • pregnant woman and protected persons
  • no affiliation to social security
  • unable to understand the information form
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Laparoscopic DA VINCI Robot Assisted coelioscopyrobot-assisted coelioscopy
2conventional coelioscopyconventional coelioscopy
Primary Outcome Measures
NameTimeMethod
Evaluate the reduction in morphine consumptionduring the postoperative 48h
Secondary Outcome Measures
NameTimeMethod
morbidityduring the study
Pain patient (ENS, total consumption of morphine)during the hospitalization, to 10 days,1 month, 6 months and 12 months of surgery
length of stay in hospital, percentage return home to 24 hours of surgeryto 24 hours of surgery
resumption of workafter surgery
quality of life (questionary SF-36)1 month, 6 month and 12 month of surgery

Trial Locations

Locations (1)

Groupe Hospitalier Chenevier-Mondor

🇫🇷

Créteil, France

© Copyright 2025. All Rights Reserved by MedPath